PXD064567 is an
original dataset announced via ProteomeXchange.
Dataset Summary
| Title | GMP-compatible extracellular vesicles prevent heart failure after a myocardial infarction through reduction of myofibroblast activation |
| Description | Ischemic heart disease is the leading cause of heart failure and mortality in the Western world. Survival after a ST-Elevation Myocardial Infarction (STEMI) has not improved over the last decade, mostly because revascularization with percutaneous coronary intervention (PCI) may, paradoxically, induce myocardial ischemia-reperfusion (MIR) injury. The injury is orchestrated by macrophages and leads to myofibroblast activation and additional scar formation. Here, we have developed a good manufacturing practice compatible protocol for the generation of an immune modulatory extracellular vesicle (EV)-rich product from bone marrow mesenchymal stromal. In blinded, placebo-controlled MIR models in mice and pigs, the EV product preserved the myocardial function in the mice hearts and was cardioprotective in the pig models of MIR. To facilitate translation to the clinic, we have also developed a positron emission tomography (PET)-based system to longitudinally detect in vivo heart myofibroblast activation and, thereby, the scar formation in mice and humans. The PET system showed that the EV-product significantly reduced myofibroblast activation and the scar size in placebo-controlled MIR-injury models in mice. In conclusion, PET-directed EV-treatment might offer an individualized additive treatment to PCI in order to prevent heart failure after STEMI. |
| HostingRepository | PRIDE |
| AnnounceDate | 2026-06-12 |
| AnnouncementXML | Submission_2026-06-12_04:25:31.794.xml |
| DigitalObjectIdentifier | |
| ReviewLevel | Peer-reviewed dataset |
| DatasetOrigin | Original dataset |
| RepositorySupport | Unsupported dataset by repository |
| PrimarySubmitter | Pierre Sabatier |
| SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: NEWT:9606; |
| ModificationList | acetylated residue; monohydroxylated residue; iodoacetamide derivatized residue |
| Instrument | Orbitrap Astral; Orbitrap Exploris 480 |
Dataset History
| Revision | Datetime | Status | ChangeLog Entry |
| 0 | 2025-06-03 08:48:02 | ID requested | |
| ⏵ 1 | 2026-06-12 04:25:32 | announced | |
Publication List
| Dataset with its publication pending |
Keyword List
| submitter keyword: extracellular vesicles, myocardial infarction |
Contact List
| Jesper Olsen |
| contact affiliation | Novo Nordisk Foundation Center for Protein Research, Department of Cellular and Molecular Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark |
| contact email | jesper.olsen@cpr.ku.dk |
| lab head | |
| Pierre Sabatier |
| contact affiliation | Department of Surgical Sciences, Uppsala University.
Novo Nordisk Foundation Center for Protein Research, University of Copenhagen. |
| contact email | pierre63.sabatier@gmail.com |
| dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2026/06/PXD064567 |
| PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD064567
- Label: PRIDE project
- Name: GMP-compatible extracellular vesicles prevent heart failure after a myocardial infarction through reduction of myofibroblast activation